February 9, 2015 / 8:07 AM / 3 years ago

BRIEF-ALK-Abelló and bioCSL enter into a partnership for allergy

Feb 9 (Reuters) - Alk Abello A/S :

* ALK and bioCSL enter into a partnership for allergy

* Announce a partnership in Australia and New Zealand which grants bioCSL exclusive rights to promote and sell ALK's slit-tablets

* Says this announcement does not impact ALK's financial guidance for 2015

* Says the deal grants bioCSL exclusive rights to promote and sell ALK's slit-tablets against house dust mite and grass pollen allergy, and ALK's Jext adrenaline auto-injector Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below